These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3608330)

  • 1. Pathologic fractures in a patient with renal osteodystrophy. Failure of early detection on bone scans.
    Campeau RJ; Bellah RD; Varma DG
    Clin Nucl Med; 1987 Jul; 12(7):510-3. PubMed ID: 3608330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal osteodystrophy.
    Parfitt AM
    Orthop Clin North Am; 1972 Nov; 3(3):681-98. PubMed ID: 4565585
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone scan appearance of renal osteodystrophy in diabetic chronic renal failure patients.
    So Y; Hyun IY; Lee DS; Ahn C; Chung JK; Kim S; Lee MC; Lee JS; Koh CS
    Radiat Med; 1998; 16(6):417-21. PubMed ID: 9929141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migratory multiple bone involvement in a patient with systemic mastocytosis.
    Lidor C; Hallel T; Oren VO
    Clin Nucl Med; 1990 Sep; 15(9):640-3. PubMed ID: 2208886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periarticular bone sites associated with traumatic injury: false-positive findings with In-111-labeled white blood cell and Tc-99m MDP scintigraphy.
    Seabold JE; Ferlic RJ; Marsh JL; Nepola JV
    Radiology; 1993 Mar; 186(3):845-9. PubMed ID: 8430197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of bone scanning to detect fractures in a woman on chronic steroid therapy.
    Scott S; Alazraki N; Manaster B
    Skeletal Radiol; 1984; 12(3):204-7. PubMed ID: 6238410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of bone gammagraphy with Tc99-methyldiphosphonate (gamma G Tc99-MDP) in renal osteodystrophy].
    Garciá Garciá M; Vallés Prats M; López Pedret J; Pons Creus JM; Botey Puig A; Herranz G-Romero R; Setoain Quinquer J; Revert Torrellas L
    Rev Clin Esp; 1981 Apr; 161(1):31-5. PubMed ID: 6454934
    [No Abstract]   [Full Text] [Related]  

  • 8. Prominent Tc-99m MIBI skeletal uptake in renal osteodystrophy: a possible role for whole-body scanning.
    Reczek J; Elgazzar A
    Clin Nucl Med; 2003 Sep; 28(9):775-7. PubMed ID: 12973007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiophosphate imaging and bone densitometry in renal osteodystrophy.
    Rosenthall L
    Curr Opin Nephrol Hypertens; 1993 Nov; 2(6):956-61. PubMed ID: 7922239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy.
    Higuchi T; Hirano T; Inoue T; Aoki J; Ueki K; Wakamatsu R; Yano S; Naruse T; Endo K
    J Nucl Med; 1998 Mar; 39(3):541-3. PubMed ID: 9529307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
    Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
    Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
    Moore AE; Blake GM; Fogelman I
    J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Delayed" appearance of positive bone scan following fracture.
    Skarzynski JJ; Sziklas JJ; Spencer RP
    Clin Nucl Med; 1985 Sep; 10(9):663-4. PubMed ID: 4064445
    [No Abstract]   [Full Text] [Related]  

  • 16. Recognition of renal osteodystrophy on bone imaging.
    Eggleston DE; Bartold K; Abghari R
    Clin Nucl Med; 1986 Aug; 11(8):543-4. PubMed ID: 3742909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factor analysis of bone mineral dynamics in patients with renal osteodystrophy].
    Koizumi Y; Okamura T; Fukuda T; Inoue Y; Oomura M; Ikeda H; Hata M; Oda J; Ochi H; Onoyama Y
    Kaku Igaku; 1989 Jul; 26(7):829-34. PubMed ID: 2810901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.
    Casas AT; Burke GJ; Sathyanarayana ; Mansberger AR; Wei JP
    Am J Surg; 1993 Oct; 166(4):369-73. PubMed ID: 8214295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum toxicity complicating renal osteodystrophy. A case report.
    Oppenheim WL; Namba R; Goodman WG; Salusky IB
    J Bone Joint Surg Am; 1989 Mar; 71(3):446-52. PubMed ID: 2925723
    [No Abstract]   [Full Text] [Related]  

  • 20. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
    Ergün EL; Kiratli PO; Günay EC; Erbaş B
    Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.